Header Logo

Connection

Danny Dhanasekaran to Humans

Back to Details
This is a "connection" page, showing publications Danny Dhanasekaran has written about Humans.
Danny Dhanasekaran
Connection Strength
0.727
Humans
  1. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
    View in: PubMed
    Score: 0.053
  2. GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 2021 08 14; 11(8).
    View in: PubMed
    Score: 0.044
  3. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
    View in: PubMed
    Score: 0.036
  4. LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res. 2018 04 15; 78(8):1923-1934.
    View in: PubMed
    Score: 0.034
  5. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer. Oncotarget. 2016 Nov 08; 7(45):72845-72859.
    View in: PubMed
    Score: 0.032
  6. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gai2, Src, and HIF1a signaling nexus. Oncotarget. 2016 Jun 21; 7(25):37664-37679.
    View in: PubMed
    Score: 0.031
  7. LPA-mediated migration of ovarian cancer cells involves translocalization of Gai2 to invadopodia and association with Src and ß-pix. Cancer Lett. 2015 Jan 28; 356(2 Pt B):382-91.
    View in: PubMed
    Score: 0.027
  8. The gep proto-oncogene Ga12 mediates LPA-stimulated activation of CREB in ovarian cancer cells. Cell Signal. 2014 Jan; 26(1):122-32.
    View in: PubMed
    Score: 0.025
  9. The gep proto-oncogene Ga13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas. 2013 Jul; 42(5):819-28.
    View in: PubMed
    Score: 0.025
  10. JNK signaling in apoptosis. Oncogene. 2008 Oct 20; 27(48):6245-51.
    View in: PubMed
    Score: 0.018
  11. MAPKs: function, regulation, role in cancer and therapeutic targeting. Oncogene. 2007 May 14; 26(22):3097-9.
    View in: PubMed
    Score: 0.016
  12. G protein regulation of MAPK networks. Oncogene. 2007 May 14; 26(22):3122-42.
    View in: PubMed
    Score: 0.016
  13. Scaffold proteins of MAP-kinase modules. Oncogene. 2007 May 14; 26(22):3185-202.
    View in: PubMed
    Score: 0.016
  14. Transducing the signals: a G protein takes a new identity. Sci STKE. 2006 Aug 08; 2006(347):pe31.
    View in: PubMed
    Score: 0.016
  15. NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024 Nov 04; 13(21).
    View in: PubMed
    Score: 0.014
  16. Three-Dimensional In Vitro Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research. Int J Biol Sci. 2024; 20(13):5293-5311.
    View in: PubMed
    Score: 0.014
  17. Tailored chemotherapy: Innovative deep-learning model customizing chemotherapy for high-grade serous ovarian carcinoma. Clin Transl Med. 2024 Sep; 14(9):e1774.
    View in: PubMed
    Score: 0.014
  18. Ovarian Cancer Cell-Conditioning Medium Induces Cancer-Associated Fibroblast Phenoconversion through Glucose-Dependent Inhibition of Autophagy. Int J Mol Sci. 2024 May 23; 25(11).
    View in: PubMed
    Score: 0.013
  19. Optical Coherence Tomography of Tumor Spheroids Identifies Candidates for Drug Repurposing in Ovarian Cancer. IEEE Trans Biomed Eng. 2023 06; 70(6):1891-1901.
    View in: PubMed
    Score: 0.012
  20. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Cancer Lett. 2022 08 28; 542:215735.
    View in: PubMed
    Score: 0.012
  21. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy. Cells. 2021 11 17; 10(11).
    View in: PubMed
    Score: 0.011
  22. Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy. Biomolecules. 2021 07 27; 11(8).
    View in: PubMed
    Score: 0.011
  23. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer. Mol Carcinog. 2021 05; 60(5):297-312.
    View in: PubMed
    Score: 0.011
  24. Ubiquitin-binding associated protein 2 regulates KRAS activation and macropinocytosis in pancreatic cancer. FASEB J. 2020 09; 34(9):12024-12039.
    View in: PubMed
    Score: 0.010
  25. Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells. Oncogene. 2019 11; 38(45):7089-7105.
    View in: PubMed
    Score: 0.010
  26. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds. Semin Cancer Biol. 2020 11; 66:34-44.
    View in: PubMed
    Score: 0.009
  27. Resveratrol as a Tumor-Suppressive Nutraceutical Modulating Tumor Microenvironment and Malignant Behaviors of Cancer. Int J Mol Sci. 2019 Feb 20; 20(4).
    View in: PubMed
    Score: 0.009
  28. Activation of LXR?/? by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer. BMC Cancer. 2018 Dec 10; 18(1):1232.
    View in: PubMed
    Score: 0.009
  29. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients. AAPS J. 2018 07 09; 20(5):82.
    View in: PubMed
    Score: 0.009
  30. Tumour microenvironment on mitochondrial dynamics and chemoresistance in cancer. Free Radic Res. 2018 Dec; 52(11-12):1271-1287.
    View in: PubMed
    Score: 0.009
  31. Cystathionine ß-synthase regulates mitochondrial morphogenesis in ovarian cancer. FASEB J. 2018 08; 32(8):4145-4157.
    View in: PubMed
    Score: 0.009
  32. Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98.
    View in: PubMed
    Score: 0.009
  33. The protein restriction mimetic Resveratrol is an autophagy inducer stronger than amino acid starvation in ovarian cancer cells. Mol Carcinog. 2017 Dec; 56(12):2681-2691.
    View in: PubMed
    Score: 0.008
  34. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
    View in: PubMed
    Score: 0.008
  35. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro. Oncotarget. 2016 Dec 13; 7(50):83148-83159.
    View in: PubMed
    Score: 0.008
  36. Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway. Cancer Res Treat. 2017 Apr; 49(2):338-349.
    View in: PubMed
    Score: 0.008
  37. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Res. 2016 08 15; 76(16):4887-96.
    View in: PubMed
    Score: 0.008
  38. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer. J Biomed Nanotechnol. 2016 Jun; 12(6):1159-73.
    View in: PubMed
    Score: 0.008
  39. Metformin induces degradation of cyclin D1 via AMPK/GSK3? axis in ovarian cancer. Mol Carcinog. 2017 02; 56(2):349-358.
    View in: PubMed
    Score: 0.008
  40. Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells. Cancer Lett. 2016 Feb 28; 371(2):347-53.
    View in: PubMed
    Score: 0.007
  41. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016 Feb 01; 371(1):30-7.
    View in: PubMed
    Score: 0.007
  42. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer. Oncotarget. 2015 Nov 10; 6(35):37367-84.
    View in: PubMed
    Score: 0.007
  43. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. 2015 Aug 21; 6(24):20327-44.
    View in: PubMed
    Score: 0.007
  44. Ovarian cancer. Biomed Res Int. 2014; 2014:764323.
    View in: PubMed
    Score: 0.007
  45. Ga12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma. Oncogene. 2015 May 28; 34(22):2910-21.
    View in: PubMed
    Score: 0.007
  46. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol. 2012 May; 82(2):116-40.
    View in: PubMed
    Score: 0.005
  47. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1. Arterioscler Thromb Vasc Biol. 2011 Apr; 31(4):921-7.
    View in: PubMed
    Score: 0.005
  48. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency. Blood. 2010 Dec 23; 116(26):6037-45.
    View in: PubMed
    Score: 0.005
  49. G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation. Carcinogenesis. 2010 Jul; 31(7):1230-7.
    View in: PubMed
    Score: 0.005
  50. Regulation of neurite outgrowth by interactions between the scaffolding protein, JNK-associated leucine zipper protein, and neuronal growth-associated protein superior cervical ganglia clone 10. J Biol Chem. 2010 Feb 05; 285(6):3548-3553.
    View in: PubMed
    Score: 0.005
  51. Phorbol 12-myristate 13-acetate (PMA) responsive sequence in Galphaq promoter during megakaryocytic differentiation. Regulation by EGR-1 and MAP kinase pathway. Thromb Haemost. 2008 Nov; 100(5):821-8.
    View in: PubMed
    Score: 0.005
  52. Alternative splice variants of phospholipase C-beta2 are expressed in platelets: effect on Galphaq-dependent activation and localization. Platelets. 2007 May; 18(3):217-23.
    View in: PubMed
    Score: 0.004
  53. Early growth response transcription factor EGR-1 regulates Galphaq gene in megakaryocytic cells. J Thromb Haemost. 2006 Dec; 4(12):2678-86.
    View in: PubMed
    Score: 0.004
  54. Human platelet Galphaq deficiency is associated with decreased Galphaq gene expression in platelets but not neutrophils. Thromb Haemost. 2002 Jan; 87(1):129-33.
    View in: PubMed
    Score: 0.003
  55. Role of m1 receptor-G protein coupling in cell proliferation in the prostate. Life Sci. 1997; 60(13-14):963-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.